Pharmacoeconomic profile of vitamin D3: in the prevention of osteoporosis
Hypovitaminosis D is one of the principal risk factors for osteoporosis. Some studies estimated that more of 40% of Italian women over sixty are osteoporotic. Osteoporotic fracture is a significant cause of morbidity and cost. In Italy, in 2002, the global burden for hip fractures in over 65-years o...
Main Author: | Orietta Zaniolo |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd Medical Publishers
2006-03-01
|
Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
Subjects: | |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/688 |
Similar Items
-
Economic Burden of Osteoporotic Patients with Fracture: Effect of Treatment With or Without Calcium/Vitamin D Supplements
by: Degli Esposti L, et al.
Published: (2020-02-01) -
The role of calcium and vitamin D medications in prevention and treatment of osteoporosis
by: Alexander S. Lutsenko, et al.
Published: (2017-12-01) -
Vitamin D Levels in Patients with Osteoporosis
by: Memet Kurt, et al.
Published: (2011-12-01) -
Clinical and pharmacoeconomic profile of esomeprazole in acid-related diseases
by: Orietta Zaniolo
Published: (2006-09-01) -
Alendronate and hormone replacement therapy in the prevention of osteoporotic fracture: a pharmacoeconomic analysis employing a net-benefit regression method of cost-effectiveness
by: Tiller, Kevin Wade
Published: (2008)